Health care acquisition

Johnson & Johnson will purchase orthopaedic device company Synthes for $21.3 billion.

Johnson & Johnson, based in New Brunswick, New Jersey, describes itself as “the world’s most comprehensive and broadly-based manufacturer...

Subscription required to view this article.

This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content

If you do not currently subscribe to FTCWatch please contact us for subscription information:

FTCWatch is delivered in the following formats: via email alert and online at